Atlas Trials

Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Clinical trial NCT00301912 · WITHDRAWN

Trial details

NCT number
NCT00301912
Sponsor
University of California, San Francisco
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
AnemiaChronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Start date
2002-01-01
Primary completion
2007-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.